Cencora Inc
COR286.930USD
+2.490+0.87%
Fechamento 04/17, 16:00（ET）Cotações atrasadas em 15 min
55.62BValor de mercado
39.84P/L TTM
Informações de Cencora Inc Empresa
Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company helps both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
Informações da empresa
Código da empresaCOR
Nome da EmpresaCencora Inc
Data de listagemMay 28, 1996
Fundado em2001
CEODr. Robert P. (Bob) Mauch, Ph.D.
Funcionários42000
Tipo de TítulosOrdinary Share
Fim do ano fiscalMay 28
Endereço1 West First Avenue
CidadeCONSHOHOCKEN
Bolsa de ValoresNYSE Consolidated
PaísUnited States of America
Código postal19428
Telefone16107277000
Sitehttps://www.cencora.com/
Código da empresaCOR
Data de listagemMay 28, 1996
Fundado em2001
Executivos da Empresa
Nome
Nome/Posição
Posição
Ações Detidas
Variação
Mr. Steven H. (Steve) Collis, CPA
Mr. Steven H. (Steve) Collis, CPA
Executive Chairman of the Board
Executive Chairman of the Board
317.91K
-0.63%
Mr. Lon R. Greenberg
Mr. Lon R. Greenberg
Independent Director
Independent Director
22.11K
+3.70%
Ms. Silvana Battaglia
Ms. Silvana Battaglia
Chief Human Resource Officer, Executive Vice President
Chief Human Resource Officer, Executive Vice President
15.37K
-24.54%
Ms. Elizabeth S. Campbell
Ms. Elizabeth S. Campbell
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
14.66K
-21.96%
Mr. Dennis M. Nally
Mr. Dennis M. Nally
Independent Director
Independent Director
12.29K
+6.86%
Mr. Werner Baumann
Mr. Werner Baumann
Independent Director
Independent Director
2.77K
+39.81%
Dr. Lorence H. Kim, M.D.
Dr. Lorence H. Kim, M.D.
Independent Director
Independent Director
957.00
+469.64%
Mr. Bennett S. Murphy
Mr. Bennett S. Murphy
Senior Vice President, Investor Relations
Senior Vice President, Investor Relations
--
--
Mr. Francois Mandeville
Mr. Francois Mandeville
Executive Vice President - Strategy and M&A
Executive Vice President - Strategy and M&A
--
--
Mr. D. Mark Durcan
Mr. D. Mark Durcan
Lead Independent Director
Lead Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações Detidas
Variação
Mr. Steven H. (Steve) Collis, CPA
Mr. Steven H. (Steve) Collis, CPA
Executive Chairman of the Board
Executive Chairman of the Board
317.91K
-0.63%
Mr. Lon R. Greenberg
Mr. Lon R. Greenberg
Independent Director
Independent Director
22.11K
+3.70%
Ms. Silvana Battaglia
Ms. Silvana Battaglia
Chief Human Resource Officer, Executive Vice President
Chief Human Resource Officer, Executive Vice President
15.37K
-24.54%
Ms. Elizabeth S. Campbell
Ms. Elizabeth S. Campbell
Executive Vice President, Chief Legal Officer
Executive Vice President, Chief Legal Officer
14.66K
-21.96%
Mr. Dennis M. Nally
Mr. Dennis M. Nally
Independent Director
Independent Director
12.29K
+6.86%
Mr. Werner Baumann
Mr. Werner Baumann
Independent Director
Independent Director
2.77K
+39.81%
Detalhamento da Receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Acionista
Tempo de atualização: sex, 21 de fev
Tempo de atualização: sex, 21 de fev
Estatísticas do Acionista
Tipo
Estatísticas do Acionista
Acionista
Proporção
The Vanguard Group, Inc.
10.96%
BlackRock Institutional Trust Company, N.A.
5.56%
Walgreens Boots Alliance Inc
5.36%
T. Rowe Price Associates, Inc.
4.44%
State Street Global Advisors (US)
4.15%
Other
69.53%
Estatísticas do Acionista
Acionista
Proporção
The Vanguard Group, Inc.
10.96%
BlackRock Institutional Trust Company, N.A.
5.56%
Walgreens Boots Alliance Inc
5.36%
T. Rowe Price Associates, Inc.
4.44%
State Street Global Advisors (US)
4.15%
Other
69.53%
Tipo
Acionista
Proporção
Investment Advisor
40.06%
Investment Advisor/Hedge Fund
38.08%
Corporation
5.36%
Research Firm
4.19%
Hedge Fund
3.92%
Pension Fund
2.08%
Bank and Trust
1.95%
Sovereign Wealth Fund
1.19%
Family Office
1.17%
Other
1.99%
Instituição Participações
Tempo de atualização: dom, 19 de jan
Tempo de atualização: dom, 19 de jan
Período do Relatório
Nº de instituições
Ações detidas
Proporção
Variação
2025Q1
2167
189.96M
98.06%
-8.34M
2024Q4
2214
199.54M
103.03%
-6.12M
2024Q3
2134
200.05M
102.56%
+474.02K
2024Q2
2090
200.10M
100.34%
-7.14M
2024Q1
2068
201.37M
100.95%
-1.37M
2023Q4
1982
202.46M
101.40%
+179.01K
2023Q3
1885
197.70M
97.79%
-2.16M
2023Q2
1870
195.01M
96.41%
-1.88M
2023Q1
1823
192.70M
95.24%
-7.51M
2022Q4
1797
190.05M
93.86%
-247.07K
Ver Mais
Atividade dos Acionistas
Nome
Ações detidas
Proporção
Variação
Chg %
Data
The Vanguard Group, Inc.
21.22M
10.96%
+5.67K
+0.03%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
10.77M
5.56%
+112.08K
+1.05%
Dec 31, 2024
Walgreens Boots Alliance Inc
10.38M
5.36%
-2.19M
-17.42%
Mar 21, 2025
T. Rowe Price Associates, Inc.
8.61M
4.44%
+71.27K
+0.84%
Dec 31, 2024
State Street Global Advisors (US)
8.03M
4.15%
-14.00K
-0.17%
Dec 31, 2024
Wellington Management Company, LLP
5.06M
2.61%
-135.53K
-2.61%
Dec 31, 2024
Boston Partners
5.01M
2.58%
+125.61K
+2.57%
Dec 31, 2024
Geode Capital Management, L.L.C.
4.33M
2.23%
+130.21K
+3.10%
Dec 31, 2024
JP Morgan Asset Management
3.45M
1.78%
+46.78K
+1.37%
Dec 31, 2024
Capital Research Global Investors
2.90M
1.5%
+4.61K
+0.16%
Dec 31, 2024
Ver Mais
ETFs Relacionados
Tempo de atualização: dom, 6 de abr
Tempo de atualização: dom, 6 de abr
Nome
Proporção
VanEck Pharmaceutical ETF
5.16%
AdvisorShares Focused Equity ETF
4.3%
Invesco Dorsey Wright Healthcare Momentum ETF
3.79%
VictoryShares US Multi-Factor Minimum Vol ETF
3.67%
Amplify Cash Flow Dividend Leaders ETF
3.56%
Indexperts Quality Earnings Focused ETF
3.04%
VanEck Retail ETF
2.81%
First Trust Consumer Staples Alphadex Fund
2.78%
Amplify Cash Flow High Income ETF
2.74%
Counterpoint Quantitative Equity ETF
2.37%
Ver Mais
VanEck Pharmaceutical ETF
Proporção5.16%
AdvisorShares Focused Equity ETF
Proporção4.3%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporção3.79%
VictoryShares US Multi-Factor Minimum Vol ETF
Proporção3.67%
Amplify Cash Flow Dividend Leaders ETF
Proporção3.56%
Indexperts Quality Earnings Focused ETF
Proporção3.04%
VanEck Retail ETF
Proporção2.81%
First Trust Consumer Staples Alphadex Fund
Proporção2.78%
Amplify Cash Flow High Income ETF
Proporção2.74%
Counterpoint Quantitative Equity ETF
Proporção2.37%
Dividendo
Um total de
1.92B
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro das ações
Data de pagamento
Data de ex-dividendo
Feb 05, 2025
COR.NB Interim Cash Dividend of gross USD 0.55 paid on Mar 03, 2025 going ex on Feb 14, 2025
Feb 14, 2025
Mar 03, 2025
Feb 14, 2025
Nov 06, 2024
COR.NB Final Cash Dividend of gross USD 0.55 paid on Nov 29, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Nov 29, 2024
Nov 15, 2024
Jul 31, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on Aug 26, 2024 going ex on Aug 09, 2024
Aug 09, 2024
Aug 26, 2024
Aug 09, 2024
May 01, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on May 24, 2024 going ex on May 09, 2024
May 10, 2024
May 24, 2024
May 09, 2024
Jan 31, 2024
COR.NB Interim Cash Dividend of gross USD 0.51 paid on Feb 26, 2024 going ex on Feb 08, 2024
Feb 09, 2024
Feb 26, 2024
Feb 08, 2024
Nov 02, 2023
COR.NB Final Cash Dividend of gross USD 0.51 paid on Nov 27, 2023 going ex on Nov 10, 2023
Nov 13, 2023
Nov 27, 2023
Nov 10, 2023
Aug 02, 2023
COR.NB Interim Cash Dividend of gross USD 0.485 paid on Aug 28, 2023 going ex on Aug 10, 2023
Aug 11, 2023
Aug 28, 2023
Aug 10, 2023
May 02, 2023
COR.NB Interim Cash Dividend of gross USD 0.485 paid on May 30, 2023 going ex on May 11, 2023
May 12, 2023
May 30, 2023
May 11, 2023
Feb 01, 2023
COR.NB Interim Cash Dividend of gross USD 0.485 paid on Feb 27, 2023 going ex on Feb 09, 2023
Feb 10, 2023
Feb 27, 2023
Feb 09, 2023
Nov 04, 2022
COR.NB Final Cash Dividend of gross USD 0.485 paid on Nov 28, 2022 going ex on Nov 10, 2022
Nov 14, 2022
Nov 28, 2022
Nov 10, 2022
Ver Mais
Desdobramento de Ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados